Rxcurve
HCPCS J2185 · per 100 MG

Meropenem

Products billed under this code include Meropenem.

Payment limit per 100 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2185

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Meropenem Hikma Pharmaceuticals USA Inc. 00143-9430-10 50 $17.90
Meropenem Hikma Pharmaceuticals USA Inc. 00143-9431-10 100 $35.80
Meropenem Pfizer Inc 00409-0222-10 50 $17.90
Meropenem Pfizer Inc 00409-1390-51 50 $17.90
Meropenem Pfizer Inc 00409-1391-22 100 $35.80
Meropenem Pfizer Inc 00409-3412-10 100 $35.80
Meropenem Sandoz Inc. 00781-3000-95 50 $17.90
Meropenem Sandoz Inc. 00781-3098-95 100 $35.80
Meropenem Sagent Pharmaceuticals 25021-0160-20 50 $17.90
Meropenem WG Critical Care, LLC 44567-0145-10 50 $17.90
Show all 31 products
ProductLabelerNDCUnits / pkgLimit / pkg
Meropenem WG Critical Care, LLC 44567-0146-10 100 $35.80
Meropenem WG Critical Care, LLC 44567-0400-10 50 $17.90
Meropenem WG Critical Care, LLC 44567-0401-10 100 $35.80
Meropenem Eugia US LLC 55150-0207-20 50 $17.90
Meropenem Eugia US LLC 55150-0208-30 100 $35.80
Meropenem FreseniUS Kabi USA, LLC 63323-0507-20 50 $17.90
Meropenem FreseniUS Kabi USA, LLC 63323-0507-21 50 $17.90
Meropenem FreseniUS Kabi USA, LLC 63323-0507-25 125 $44.75
Meropenem FreseniUS Kabi USA, LLC 63323-0508-25 250 $89.50
Meropenem FreseniUS Kabi USA, LLC 63323-0508-30 100 $35.80
Meropenem FreseniUS Kabi USA, LLC 63323-0508-31 100 $35.80
Meropenem Amneal Pharmaceuticals, LLC 70121-1453-07 100 $35.80
Meropenem Amneal Pharmaceuticals, LLC 70121-1454-07 50 $17.90
Meropenem Xellia Pharmaceuticals USA, LLC. 70594-0075-02 50 $17.90
Meropenem Xellia Pharmaceuticals USA, LLC. 70594-0076-02 100 $35.80
Meropenem Armas Pharmaceuticals Inc. 72485-0411-10 50 $17.90
Meropenem Armas Pharmaceuticals Inc. 72485-0412-10 100 $35.80
Meropenem Civica, Inc. 72572-0410-10 100 $35.80
Meropenem Civica, Inc. 72572-0412-10 50 $17.90
Meropenem Civica, Inc. 72572-0415-10 50 $17.90
Meropenem Civica, Inc. 72572-0416-10 100 $35.80

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.358 +$0.033 100 MG Meropenem v1, posted September 17, 2026
3Q26 $0.325 −$0.046 100 MG Meropenem v1, posted September 15, 2026
2Q26 $0.371 −$0.012 100 MG Meropenem v1, posted September 15, 2026
1Q26 $0.383 −$0.038 100 MG Meropenem v1, posted September 15, 2026
4Q25 $0.421 −$0.015 100 MG Meropenem v1, posted September 8, 2026
3Q25 $0.436 +$0.005 100 MG Meropenem v1, posted March 10, 2026
2Q25 $0.431 +$0.043 100 MG Meropenem v1, posted March 10, 2026
1Q25 $0.388 +$0.034 100 MG Meropenem v1, posted December 19, 2025
4Q24 $0.354 +$0.033 100 MG Meropenem v1, posted June 11, 2025
3Q24 $0.321 −$0.066 100 MG Meropenem v1, posted June 11, 2025
2Q24 $0.387 −$0.065 100 MG Meropenem v1, posted March 11, 2025
1Q24 $0.452 −$0.11 100 MG Meropenem v1, posted December 19, 2024
4Q23 $0.562 +$0.044 100 MG Meropenem v1, posted October 10, 2024
3Q23 $0.518 +$0.023 100 MG Meropenem v1, posted June 5, 2024
2Q23 $0.495 −$0.126 100 MG Meropenem v1, posted February 23, 2024
1Q23 $0.621 −$0.104 100 MG Meropenem v1, posted December 6, 2023
4Q22 $0.725 +$0.026 100 MG Meropenem v1, posted June 22, 2023
3Q22 $0.699 +$0.006 100 MG Meropenem v1, posted June 9, 2023
2Q22 $0.693 −$0.05 100 MG Meropenem v1, posted December 14, 2022
1Q22 $0.743 −$0.051 100 MG Meropenem v1, posted June 8, 2022
4Q21 $0.794 −$0.025 100 MG Meropenem v1, posted June 2, 2022
3Q21 $0.819 +$0.034 100 MG Meropenem v1, posted June 2, 2022
2Q21 $0.785 +$0.022 100 MG Meropenem v1, posted March 1, 2022
1Q21 $0.763 – 100 MG Meropenem v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files